{"id":"W2207823877","doi":"10.3111/13696998.2015.1131705","title":"Real-world dosing and drug costs with everolimus or axitinib as second targeted therapies for advanced renal cell carcinoma: a retrospective chart review in the US","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Comprehensive Cancer Network; Canadian Centre for Applied Research in Cancer Control","keywords":"Axitinib; Everolimus; Medicine; Sunitinib; Hazard ratio; Internal medicine; Renal cell carcinoma; Pazopanib; Oncology; Sorafenib; Retrospective cohort study; Dosing; Discontinuation; Confidence interval; Hepatocellular carcinoma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001684907,0.0002164801,0.0003999492,0.003247016,0.0003410147,0.0008343795,0.0004613267,0.0003572447,0.000814544],"category_scores_gemma":[0.007156921,0.0003170886,0.0004952102,0.00606738,0.0003096992,0.0006150251,0.0004178072,0.0003196107,0.0001675918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001709262,"about_ca_system_score_gemma":0.001926059,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02332569,"about_ca_topic_score_gemma":0.02208847,"domain_scores_codex":[0.996996,0.0006560097,0.0009480163,0.000416659,0.0008165637,0.0001667716],"domain_scores_gemma":[0.9818463,0.002564498,0.01299787,0.0004278041,0.00186661,0.0002968911],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006846726,0.0000202954,0.9950004,0.0001258196,0.00008625408,0.0003840238,0.0001571519,0.0001161194,0.00009115487,0.00003441903,0.0006001643,0.003315654],"study_design_scores_gemma":[0.00001296893,0.00008459432,0.9944178,0.0001069058,0.0000745254,0.001674304,0.000494136,0.0004277987,0.0002941749,0.0000184125,0.002382308,0.00001211179],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809417,0.005482639,0.0005630422,0.0002369024,0.00001497296,0.0001707609,0.01113222,0.00002887036,0.001429017],"genre_scores_gemma":[0.9920879,0.002126075,0.0007278763,0.0001366243,0.00002259892,0.00008303888,0.004640319,0.000009759065,0.000165848],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02332569,"threshold_uncertainty_score":0.0463798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02393487756643908,"score_gpt":0.2883542912529376,"score_spread":0.2644194136864985,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}